PyroGenesis Plasma-Based Solution Achieves Successful Destruction of PFAS “Forever Chemicals”
PyroGenesis has successfully completed a $2.25 million contract for the delivery and operation of its plasma torch system to destroy PFAS 'forever chemicals'. The project, funded by the U.S. Department of Defense, has already treated over 300 tonnes of PFAS-contaminated materials at full capacity using a 1MW plasma torch system. The technology addresses a significant environmental and health concern, targeting a global PFAS remediation market estimated at $250 billion, with the U.S. portion valued at approximately $200 billion. PFAS are synthetic chemicals found in various consumer and industrial products, linked to health issues including increased cancer risk and immune system effects.
PyroGenesis ha completato con successo un contratto da 2,25 milioni di dollari per la fornitura e l'operazione del suo sistema a torcia al plasma per distruggere i PFAS, le 'sostanze chimiche per sempre'. Il progetto, finanziato dal Dipartimento della Difesa degli Stati Uniti, ha già trattato oltre 300 tonnellate di materiali contaminati da PFAS a piena capacità utilizzando un sistema a torcia al plasma da 1 MW. Questa tecnologia affronta una significativa preoccupazione ambientale e per la salute, mirando a un mercato globale di bonifica dei PFAS stimato in 250 miliardi di dollari, con la parte statunitense valutata a circa 200 miliardi di dollari. I PFAS sono sostanze chimiche sintetiche presenti in vari prodotti di consumo e industriali, collegate a problemi di salute, tra cui un aumento del rischio di cancro e effetti sul sistema immunitario.
PyroGenesis ha culminado con éxito un contrato de 2,25 millones de dólares para la entrega y operación de su sistema de antorcha de plasma destinado a destruir los PFAS, los 'químicos para siempre'. El proyecto, financiado por el Departamento de Defensa de los Estados Unidos, ya ha tratado más de 300 toneladas de materiales contaminados con PFAS a plena capacidad utilizando un sistema de antorcha de plasma de 1 MW. Esta tecnología aborda una preocupación significativa para el medio ambiente y la salud, enfocándose en un mercado global de remediación de PFAS estimado en 250 mil millones de dólares, con la parte correspondiente a Estados Unidos valorada en aproximadamente 200 mil millones de dólares. Los PFAS son productos químicos sintéticos que se encuentran en varios productos de consumo e industriales, y están relacionados con problemas de salud, incluidos el aumento del riesgo de cáncer y efectos en el sistema inmunológico.
PyroGenesis는 PFAS '영원한 화학물질'을 파괴하기 위해 플라스마 토치 시스템의 납품과 운영을 위한 225만 달러 계약을 성공적으로 완료했습니다. 미국 국방부의 자금 지원을 받은 이 프로젝트는 1MW 플라스마 토치 시스템을 사용하여 PFAS로 오염된 자재 300톤 이상을 처리했습니다. 이 기술은 2500억 달러로 추정되는 전세계 PFAS 정화 시장을 목표로 하여 환경과 건강에 대한 중요한 우려를 해결합니다. 미국 시장의 가치는 약 2000억 달러로 평가됩니다. PFAS는 다양한 소비재 및 산업 제품에서 발견되는 합성 화학물질로, 암 위험 증가 및 면역 체계 영향과 같은 건강 문제와 관련이 있습니다.
PyroGenesis a réussi à finaliser un contrat de 2,25 millions de dollars pour la livraison et l'exploitation de son système de torche plasma afin de détruire les PFAS, les 'produits chimiques éternels'. Ce projet, financé par le département de la Défense des États-Unis, a déjà traité plus de 300 tonnes de matériaux contaminés par les PFAS à pleine capacité grâce à un système de torche plasma de 1 MW. Cette technologie répond à une préoccupation environnementale et de santé majeure, ciblant un marché mondial de remédiation des PFAS estimé à 250 milliards de dollars, dont la part américaine est évaluée à environ 200 milliards de dollars. Les PFAS sont des produits chimiques synthétiques que l'on trouve dans divers produits de consommation et industriels, liés à des problèmes de santé, notamment un risque accru de cancer et des effets sur le système immunitaire.
PyroGenesis hat erfolgreich einen Vertrag über 2,25 Millionen Dollar für die Lieferung und den Betrieb seines Plasmapulver-Systems zur Zerstörung von PFAS, den 'Für-Immer-Chemikalien', abgeschlossen. Das Projekt, das vom US-Verteidigungsministerium finanziert wird, hat bereits über 300 Tonnen mit PFAS kontaminierter Materialien bei voller Kapazität mit einem 1-MW-Plasmapulver-System behandelt. Diese Technologie hebt ein erhebliches Umwelt- und Gesundheitsproblem hervor und zielt auf einen globalen PFAS-Remediationsmarkt ab, der auf etwa 250 Milliarden Dollar geschätzt wird, wobei der US-Anteil auf etwa 200 Milliarden Dollar geschätzt wird. PFAS sind synthetische Chemikalien, die in verschiedenen Verbrauchs- und Industriegütern vorkommen und mit Gesundheitsproblemen in Verbindung stehen, darunter ein erhöhtes Krebsrisiko und Auswirkungen auf das Immunsystem.
- Successful completion of $2.25M contract with U.S. Department of Defense
- Successfully treated over 300 tonnes of PFAS-contaminated materials
- Targeting large addressable market worth $250B globally
- Technology proven effective at full capacity operation
- None.
Success opens door for PyroGenesis’ role in global PFAS treatment
MONTREAL, Dec. 03, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, announced the successful completion of a contract for the delivery, commissioning, and operation of its plasma torch system to destroy harmful Perfluoroalkyl and Polyfluoroalkyl Substances (“PFAS”). PFAS are widely known as “forever chemicals” due to a strong molecular bond that resists degradation and have been connected to worldwide health issues. The project is funded by the U.S. Department of Defense, which is seeking various PFAS-remediation technologies as part of its broader environmental clean-up mandate. The name of the client has been kept anonymous for confidentiality and competitive reasons.
Under the previously announced contract, PyroGenesis received
“We are extremely pleased by how our plasma-based system safely treated and destroyed these PFAS. PFAS are insidious, dangerous chemicals that unfortunately are showing up in more and more places, in particular water and soil. We consider PFAS to not only be an environmental concern, but an immediate and serious health concern as well, and we are proud to be able to provide a solution towards their elimination,” said P. Peter Pascali, President and CEO of PyroGenesis. “These successful real-world operational results demonstrate that PyroGenesis’ plasma torch systems can now be considered among the long-term PFAS remediation strategies being considered by governments everywhere as they begin to search for ways to deal with this rising health crisis.”
PFAS include more than 14,000 man-made synthetic chemicals that have been widely used in consumer and industrial products found in numerous industries (including aerospace, automotive, and construction), for many decades.1 Research indicates that exposure to certain PFAS could result in harmful health outcomes, including an increased risk of cancer, increased cholesterol levels, and immune system effects. Products that may contain PFAS include nonstick cookware, stain resistant coatings used on carpets, upholstery, and other fabrics, water resistant clothing, firefighting foam, cleaning products, personal care and cosmetics products and many other products that resist grease, water and oil. As a result of their widespread use and strong chemical bonds and properties, which account for their persistence in the environment, PFAS are proving to be persistent pollutants. They affect humans and wildlife, as they both have been exposed to these chemicals as they consume contaminated water/food, use products made with PFAS, or breathe air contaminated by PFAS.2
The addressable market for PFAS remediation, according to global infrastructure consulting firm AECOM, suggests that the U.S. remediation opportunity is approximately
“The use of PyroGenesis’ plasma torches for the treatment of PFAS-contaminated material is yet another example of the many uses for PyroGenesis’ plasma technologies that we are developing and bringing to market, in addition to the impact PyroGenesis’ plasma systems are already having in process optimization, energy transition and energy security, carbon reduction, and commodity/supply chain security,” continued Mr. Pascali. “As our work continues to yield opportunities where our plasma technology can play a major and even a disruptive role, PyroGenesis’ solutions are becoming more readily accepted by heavy industry, manufacturing, and the military. With this successful PFAS treatment contract, PyroGenesis’ plasma technology can now also be considered in helping impact global public health on a broad scale.”
“Above and beyond the results announced today, is the impact such successes are having on the overall acceptance of PyroGenesis’ offerings,” said David D’Aoust, Senior Sales Manager at PyroGenesis. “As PyroGenesis builds on its success of introducing its low megawatt (less than 1 MW) plasma torches and expertise into mainstream industry, interesting opportunities are developing at higher power levels (greater than 1 MW). This is evident from a recent press release (PyroGenesis Signs Landmark
PyroGenesis’ involvement in the safe destruction of harmful chemicals such as PFAS is part of its three-tiered solution ecosystem that aligns with economic drivers that are key to global heavy industry. Plasma torches for use in waste destruction applications are part of PyroGenesis’ Waste Remediation tier, encompassing the safe destruction of hazardous materials, and the recovery and valorization of underlying substances such as chemicals and minerals. The other tiers are Energy Transition and Emission Reduction, and Commodity Security and Optimization.
About PyroGenesis Inc.
PyroGenesis, a high-tech company, is a proud leader in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions which reduce greenhouse gases (GHG) and are economically attractive alternatives to conventional “dirty” processes. PyroGenesis has created proprietary, patented and advanced plasma technologies that are being vetted and adopted by multiple multibillion dollar industry leaders in four massive markets: iron ore pelletization, aluminum, waste management, and additive manufacturing. With a team of experienced engineers, scientists and technicians working out of its Montreal office, and its 3,800 m2 and 2,940 m2 manufacturing facilities, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The operations are ISO 9001:2015 and AS9100D certified, having been ISO certified since 1997. PyroGenesis’ shares are publicly traded on the TSX in Canada (TSX: PYR), the OTCQX in the US (OTCQX: PYRGF), and the Frankfurt Stock Exchange in Germany (FRA: 8PY).
Cautionary and Forward-Looking Statements
This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management’s current beliefs, expectations, estimates and projections regarding future events and operating performance.
Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by PyroGenesis as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under “Risk Factors” in PyroGenesis’ latest annual information form, and in other periodic filings that it has made and may make in the future with the securities commissions or similar regulatory authorities, all of which are available under PyroGenesis’ profile on SEDAR+ at www.sedarplus.ca. These factors are not intended to represent a complete list of the factors that could affect PyroGenesis. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. PyroGenesis undertakes no obligation to publicly update or revise any forward-looking statement, except as required by applicable securities laws.
Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQX Best Market accepts responsibility for the adequacy or accuracy of this press release.
For further information please contact:
Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
E-mail: ir@pyrogenesis.com
http://www.pyrogenesis.com
1 https://www.cspinet.org/article/what-know-about-risks-pfas
2 https://www.niehs.nih.gov/health/topics/agents/pfc
3 https://investors.aecom.com/static-files/2dfcf5c0-ab90-4e1c-a53d-3138f669f54e
FAQ
What is the value of PyroGenesis (PYRGF) PFAS treatment contract?
How much PFAS-contaminated material has PyroGenesis (PYRGF) treated so far?
What is the market size for PFAS remediation that PyroGenesis (PYRGF) is targeting?